3Suppliers
4Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Belite Bio, Inc (BLTE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships
3Distinct source URLs
5High confidence
0.784Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Belite Bio, Inc Suppliers

TickerNameConfidenceEvidence
COLUMBIA-UNIVERSITY COLUMBIA-UNIVERSITY 90% We are party to an exclusive license agreement with Columbia University under which we are granted rights to intellectual property that are necessary to our business
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from BLTE graph: rting, reporting of certain deviations and adverse experiences, providing the regulatory authorities with updated sa…
ORANY ORANY 72% rting, reporting of certain deviations and adverse experiences, providing the regulatory authorities with updated safety and efficacy information, drug sampling and distribution requirements, and com…

Belite Bio, Inc Customers

TickerNameConfidenceEvidence
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from BLTE graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from BLTE graph: rting, reporting of certain devia…
ORANY ORANY 72% rting, reporting of certain deviations and adverse experiences, providing the regulatory authorities with updated safety and efficacy information, drug sampling and distribution requirements, and com…
DB Deutsche Bank Aktiengesellschaft 62% Reciprocal relationship from DB graph: Reciprocal relationship from BLTE graph: Reciprocal relationship from DB graph: Reciprocal relationship from BLTE graph: Reciprocal relationship from DB graph: …
LIN-BIOSCIENCE-INTERNATIONAL-LTD LIN-BIOSCIENCE-INTERNATIONAL-LTD 62% e highest industry standards to select the CROs that are going to conduct the services in order to meet FDA and other regulatory requirements. Manufacturing and Supply We currently rely on high-quali…

Belite Bio, Inc Debt Obligations

InstrumentDescriptionConfidenceEvidence
BLTE-DEBT-8264 Warrants outstanding: 102993000 90% xbrl warrant detail from xbrl 2025-12-31.
BLTE-DEBT Debt stack $429,000 90% Market cache reports total debt of $429,000.
BLTE-DEBT-8265 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Belite Bio, Inc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Belite Bio, Inc.

Belite Bio, Inc Ownership

HolderNameConfidenceEvidence
BLTE-OWNER-DARWIN-GLOBAL-MANAGEMENT-LTD Darwin Global Management, Ltd. 90% 13F overlay lists Darwin Global Management, Ltd. as top holder; 77 tracked holders.

Belite Bio, Inc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DB Deutsche Bank Aktiengesellschaft 100.00 1 ['customer']
ORANY ORANGE 100.00 1 ['customer', 'supplier']
BCDRF Banco Santander, S.A. 50.00 2
BLSH Bullish 50.00 2
ASBPW Aspire Biopharma Holdings, Inc. 50.00 2
BALY Bally's Corporation 50.00 2
AMXOF AMERICA MOVIL SAB DE CV/ 50.00 2
CMCM Cheetah Mobile Inc. 50.00 2
BFRIW Biofrontera Inc. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
CPT Camden Property Trust 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
ARQQW Arqit Quantum Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
BFRGW BullFrog AI Holdings, Inc. 50.00 2
D Dominion Energy, Inc. 50.00 2
DBB Invesco DB Base Metals Fund 50.00 2
DBO Invesco DB Oil Fund 50.00 2
BDRX Biodexa Pharmaceuticals Plc 50.00 2
🔐
BLTE
Unlock BLTE Supply Chain Data
Verified relationships include:
COLUMBIA-UNIVERSITYCOLUMBIA-UNIVERSITYSupplier90%
ORANYORANYSupplier72%
ORANYORANYCustomer72%
ORANYORANYCustomer72%
+7 more relationships locked
Subscribe, View plans →